Cameroon

in page functions
[French]
Total population (2015) 23,344,111
Birth cohort (2015) 846,800
Surviving Infants (surviving to 1 year per year, 2015) 788,149
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 88/1000
World Bank Index, IDA (2012) 3.17
Gross Nation Income (per capita US$, 2014) 1,350
Co-financing status (2016) Preparatory transition
No. of districts/territories (2014) 187

Gavi support for Cameroon

Type of support

Approvals

2001-2020 (US$)
(30 Nov 2015)

Commitments

2001-2020 (US$)
(30 Nov 2015)

Disbursements

2000-2015 (US$)
(30 Nov 2015)

% Disbursed

(30 Nov 2015)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cash Support (CASHSUPP) $203,000 $228,000 $203,000 100%
Civil Society Organisation support (CSO) $56,199 N/A
Health system strengthening (HSS 1) $6,964,448 $6,964,448 $6,964,448 100%
HPV Demo (NVS) $496,735 $496,735 $493,787 99%
Immunisation services support (ISS) $7,983,620 $7,983,620 $7,983,620 100%
Injection safety support (INS) $992,844 $992,844 $992,844 100%
IPV (NVS) $1,858,500 $2,822,000 $1,331,273 72%
Measles-Rubella (NVS) $7,038,500 $7,038,500 $6,782,037 96%
Meningitis A - campaign (NVS) $4,324,774 $4,324,774 $4,324,774 100%
Meningitis A - operational costs (OPC) $2,508,980 $2,508,980 $2,508,980 100%
MR - Operational costs (OPC) $5,828,500 $5,828,500 $5,828,500 100%
Penta (NVS) $40,064,436 $40,064,436 $36,009,725 90%
Pneumo (NVS) $70,360,454 $70,360,454 $72,712,780 103%
Rotavirus (NVS) $9,772,500 $9,772,500 $6,359,186 65%
Tetra DTP-HepB (NVS) $9,000,675 $9,000,675 $9,000,675 100%
Vaccine Introduction Grant (VIG) $2,855,500 $2,855,500 $2,755,500 96%
Yellow Fever (NVS) $6,393,203 $6,393,203 $6,243,786 98%
Total $176,646,668 $177,635,168 $170,551,112

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Cameroon DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 87%
M:F sex ratio at birth (2015) 1.03
Household survey: DTP3 coverage for male (2011) 68.10%
Household survey: DTP3 coverage for female (2011) 68.60%
Household survey: Last DTP3 survey (2011) 68%
% districts achieving > 80% DTP3 coverage (2014) 71%
% districts achieving < 50% DTP3 coverage (2014) 1%
MCV WHO/UNICEF estimates (2014) 80%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$27,293,090 $143,258,016

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Cameroon

03 December 2015

First use of Gavi Cholera Stockpile - Cameroon 2015

A short film explaining how Gavi came to support a global cholera vaccine stockpile, and showing the impact this has had on the vaccine market and in Cameroon where it was first deployed.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

18 August 2015

Cameroon cholera campaign

People in Cameroon to be protected against cholera with Gavi-supported vaccine

More than 110,000 doses of oral cholera vaccine will protect people in the northern region.

close icon

modal window here